Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Clasificación en acciones #34057
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Precio por acción
$0.223
Última sincronización: 2026-08-14
Capitalización bursátil
$6.32M
Cambio (1 día)
1.64%
Cambio (1 año)
-
País
US
Comercio Curanex Pharmaceuticals Inc Common Stock (CURX)

Categoría

Historial de rendimiento por dividendo de Curanex Pharmaceuticals Inc Common Stock (CURX)
Rendimiento por dividendo (TTM) de Curanex Pharmaceuticals Inc Common Stock (símbolo bursátil: CURX) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Curanex Pharmaceuticals Inc Common Stock (CURX) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.48%
BE